Bank of New York Mellon’s Adamas Pharmaceuticals, Inc. ADMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
Sell
-128,347
Closed -$630K 4692
2021
Q3
$630K Buy
128,347
+46,220
+56% +$227K ﹤0.01% 3664
2021
Q2
$433K Sell
82,127
-3,128
-4% -$16.5K ﹤0.01% 3835
2021
Q1
$409K Sell
85,255
-2,796
-3% -$13.4K ﹤0.01% 3793
2020
Q4
$381K Buy
88,051
+32,737
+59% +$142K ﹤0.01% 3740
2020
Q3
$227K Buy
55,314
+41,308
+295% +$170K ﹤0.01% 3807
2020
Q2
$36K Sell
14,006
-65,907
-82% -$169K ﹤0.01% 4016
2020
Q1
$231K Sell
79,913
-536
-0.7% -$1.55K ﹤0.01% 3690
2019
Q4
$305K Sell
80,449
-2,093
-3% -$7.94K ﹤0.01% 3791
2019
Q3
$422K Sell
82,542
-2,006
-2% -$10.3K ﹤0.01% 3632
2019
Q2
$524K Sell
84,548
-4,824
-5% -$29.9K ﹤0.01% 3571
2019
Q1
$635K Buy
89,372
+1,966
+2% +$14K ﹤0.01% 3431
2018
Q4
$746K Sell
87,406
-161,336
-65% -$1.38M ﹤0.01% 3265
2018
Q3
$4.98M Buy
248,742
+2,390
+1% +$47.9K ﹤0.01% 2417
2018
Q2
$6.36M Buy
246,352
+27,696
+13% +$715K ﹤0.01% 2263
2018
Q1
$5.23M Buy
218,656
+107,835
+97% +$2.58M ﹤0.01% 2329
2017
Q4
$3.76M Buy
110,821
+49,548
+81% +$1.68M ﹤0.01% 2481
2017
Q3
$1.3M Sell
61,273
-2,064
-3% -$43.7K ﹤0.01% 3085
2017
Q2
$1.11M Sell
63,337
-2,493
-4% -$43.6K ﹤0.01% 3193
2017
Q1
$1.15M Buy
65,830
+1,563
+2% +$27.4K ﹤0.01% 3161
2016
Q4
$1.09M Buy
64,267
+7,334
+13% +$124K ﹤0.01% 3217
2016
Q3
$935K Sell
56,933
-3,349
-6% -$55K ﹤0.01% 3213
2016
Q2
$912K Buy
60,282
+10,802
+22% +$163K ﹤0.01% 3202
2016
Q1
$715K Sell
49,480
-11,719
-19% -$169K ﹤0.01% 3252
2015
Q4
$1.73M Buy
61,199
+5,248
+9% +$149K ﹤0.01% 2802
2015
Q3
$937K Buy
55,951
+1,071
+2% +$17.9K ﹤0.01% 3202
2015
Q2
$1.44M Buy
54,880
+20,716
+61% +$543K ﹤0.01% 3131
2015
Q1
$597K Buy
34,164
+2,069
+6% +$36.2K ﹤0.01% 3535
2014
Q4
$557K Buy
+32,095
New +$557K ﹤0.01% 3575